Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease
Alzheimer’s disease (AD) is an age-associated neurodegenerative disease with no effective treatments. The translocator protein (TSPO) has been identified as a promising therapeutic target in AD, as TSPO ligands reduce the accumulation of beta-amyloid. However, the role of TSPO in other aspects of AD...
Saved in:
Main Author: | Fairley, Lauren H. |
---|---|
Other Authors: | Anna Barron |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease
by: Fairley, Lauren H., et al.
Published: (2023) -
Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease
by: Fairley, Lauren H., et al.
Published: (2021) -
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
by: Chua, Xin Ying, et al.
Published: (2021) -
Development of immunomodulatory RNA therapeutics for immune disorders
by: Iyer, Vaishnavi Srinivasan
Published: (2022) -
Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease
by: Nalini Schaduangrat, et al.
Published: (2020)